- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Idiopathic Pulmonary Fibrosis With Acute Exacerbation in United Kingdom
Total 292 results
-
Sunshine Lake Pharma Co., Ltd.CompletedIdiopathic Pulmonary FibrosisUnited States
-
SanofiCompletedIdiopathic Pulmonary FibrosisCzechia, Korea, Republic of, Mexico, Israel, Spain, Greece, Chile, Canada, Colombia, Turkey, Denmark, France, United States, Argentina, Australia, Germany, Italy, Portugal, United Kingdom
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited Kingdom, Belgium, Germany, France, Sweden, Austria, Denmark, Italy
-
Sunshine Lake Pharma Co., Ltd.CovanceCompletedIdiopathic Pulmonary FibrosisUnited States
-
Nitto Denko CorporationCompletedIdiopathic Pulmonary FibrosisUnited States, Germany, Japan, United Kingdom
-
Bridge Biotherapeutics, Inc.KCRN Research, LLCCompletedIdiopathic Pulmonary FibrosisUnited States
-
University of PittsburghUniversity of Pennsylvania; Milton S. Hershey Medical Center; Temple University; Geisinger ClinicCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedPulmonary FibrosisSpain, Belgium, Canada, Germany, China, United Kingdom, Australia, Ireland, Italy, Mexico, Netherlands, Portugal, Argentina, France, Russian Federation, Greece, Czechia, Brazil, Bulgaria, Chile, Hungary
-
CSL BehringCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, United Kingdom, Australia, Germany, Poland, Belgium, Austria, Denmark, Italy, Spain
-
MediciNovaCompletedIdiopathic Pulmonary Fibrosis | IPFUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Canada, Belgium, Australia, United Kingdom, Germany, Italy, France, Japan, Mexico, India
-
University of NottinghamNottingham University Hospitals NHS TrustRecruitingIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Japan, Belgium, Taiwan, Denmark, Germany, United Kingdom, Greece, Australia, Czechia, Brazil, Chile, Peru, Turkey
-
BiogenTerminatedIdiopathic Pulmonary FibrosisUnited States, Italy, Belgium, Czechia, Russian Federation, Korea, Republic of, Australia, France, Israel, Spain, Poland, Netherlands, Denmark, Greece, Argentina, Chile, United Kingdom
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Trevi TherapeuticsRecruitingIdiopathic Pulmonary FibrosisUnited Kingdom, Australia, Netherlands, Spain, Italy, Turkey, Poland, Chile, Canada, Germany
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States
-
The National Institutes of Pharmaceutical R&D Co...CompletedIdiopathic Pulmonary FibrosisUnited States
-
Excalibur Pharmaceuticals, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
InterMuneTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | Lung DiseaseUnited States
-
InterMuneTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | Lung DiseaseUnited States
-
University of PittsburghWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Korea, Republic of, Australia, Italy, United Kingdom, Germany, China, Finland, Denmark, Netherlands, Greece, Argentina, Austria, Chile, Czechia, Hungary, Japan, Poland, Russian Federation, Ukraine
-
Steward St. Elizabeth's Medical Center of Boston...Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesCompletedIdiopathic Pulmonary FibrosisUnited States
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Michael DonahoeCompleted
-
InterMuneCompletedPulmonary Fibrosis | Lung DiseaseUnited States
-
CelgeneTerminatedPathologic Processes | Fibrosis | Respiratory Tract Diseases | Lung Diseases | Idiopathic Pulmonary Fibrosis | Lung Diseases, Interstitial | Idiopathic Interstitial PneumoniasUnited States, Australia, Colombia, United Kingdom, Russian Federation, Brazil, Germany, Canada, Greece, Romania, Taiwan, Turkey, Ukraine
-
Joseph C. WuNot yet recruitingIdiopathic Pulmonary FibrosisUnited States
-
University of Alabama at BirminghamCompletedIdiopathic Pulmonary FibrosisUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedIdiopathic Pulmonary FibrosisUnited States
-
Vanderbilt University Medical CenterTerminatedIdiopathic Pulmonary FibrosisUnited States
-
University of PittsburghActive, not recruitingPulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimApproved for marketingIdiopathic Pulmonary FibrosisUnited States
-
Cellular Sciences, inc.Family First Medical Research CenterRecruiting
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
Hal ChapmanMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
University of Alabama at BirminghamRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Temple UniversityBoehringer IngelheimActive, not recruiting
-
Stanford UniversityCelgene CorporationWithdrawnPulmonary FibrosisUnited States
-
Modern Biosciences LtdRecruitingIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Israel, France, Germany, Greece, Hungary, Italy, Spain
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Germany, Peru, Mexico, Poland, France, Italy, United Kingdom, Australia, Canada, Spain, Japan
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
Boehringer IngelheimTerminatedIdiopathic Pulmonary FibrosisUnited States